Multidisciplinary Approaches to Optimize Migraine Management

The discussion also focused on patient-centered outcomes and medication tolerability in migraine management. Contreras emphasized that improvements in functional outcomes and quality of life often matter more to patients than traditional pain metrics. He recommended using validated patient-reported outcome measures, such as the Migraine Disability Assessment (MIDAS), and leveraging real-world evidence on functional recovery, reduction in emergency department visits, and patient satisfaction to inform coverage decisions, formulary reviews, and potential value-based contracting initiatives.

Medication tolerability was highlighted as a key factor in adherence and clinical effectiveness. Patients who have experienced prior side effects—such as sedation, cognitive fog, or cardiovascular risk—may hesitate to try new therapies. Well-tolerated medications build patient confidence, promote timely use during migraine episodes, and prevent delays that worsen symptoms. Ensuring therapies are effective and minimally disruptive improves adherence and accelerates functional recovery, allowing patients to return to daily activities more quickly.

Contreras also underscored the importance of a multidisciplinary care model that includes patient advocates, pharmacists, care managers, and behavioral health specialists. This team-based approach reinforces the value of therapy, provides education, and ensures that patients’ voices are included in coverage and access discussions. Combining patient-reported outcomes, tolerability, real-world evidence, and coordinated care supports a holistic approach to migraine management, improving both clinical outcomes and overall quality of life for patients.